8-K: Select Medical Holdings Corporation Approves Non-Employee Director Compensation Policy and Charter Amendment

Select Medical Holdings Corporation's stockholders approved a new Non-Employee Director Compensation Policy and an amendment to the company's charter at the annual meeting on April 24, 2025.

Summary

• Select Medical Holdings Corporation held its annual meeting of stockholders on April 24, 2025, where several proposals were approved.
• The stockholders approved the Non-Employee Director Compensation Policy, which outlines cash and equity compensation for non-employee directors.
• The policy includes a quarterly cash retainer of $18,000, with an option to receive fully-vested shares of common stock in lieu of cash.
• Attendance fees are $3,000 per in-person Board meeting and $600 per telephonic Board meeting.
• Fees are also provided for participation on committees of the Board.
• The stockholders also approved an amendment to the Amended and Restated Certificate of Incorporation, eliminating supermajority voting requirements.
• This amendment reduces the voting threshold to a majority of outstanding shares to amend the Bylaws and certain provisions of the Charter.
• An amendment to the Bylaws was also approved, reducing the voting threshold to a majority of outstanding shares to amend the Bylaws and remove a Director for cause.
• The amendment to the Charter became effective on April 28, 2025, upon filing with the Delaware Secretary of State.
• The stockholders also elected four Class I Directors to the Board: Russell L. Carson, Katherine R. Davisson, William H. Frist, and Marilyn B. Tavenner.
• The appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures and compensation policies. The sentiment is neutral to positive as the changes are generally viewed as shareholder-friendly.

Positives

• The elimination of supermajority voting requirements could make the company more agile and responsive to shareholder concerns.
• The option for directors to receive stock in lieu of cash may align their interests more closely with those of shareholders.
• The approval of director nominees ensures continuity and stability in leadership.

Future Outlook

The company will continue to operate under the amended charter and bylaws, and the Non-Employee Director Compensation Policy will guide compensation decisions for non-employee directors.

Industry Context

Corporate governance practices are increasingly focused on shareholder rights and aligning director compensation with company performance. The elimination of supermajority voting requirements is a trend seen in many public companies to enhance shareholder influence.

Comparison to Industry Standards

• Eliminating supermajority voting requirements aligns Select Medical with companies like HCA Healthcare and Universal Health Services, which also operate with majority voting rules.
• The director compensation structure, including cash retainers and equity grants, is comparable to that of other publicly traded healthcare providers such as Tenet Healthcare and Community Health Systems.
• The specific amounts may vary based on company size and performance, but the overall structure is consistent with industry norms.

Corporate Governance

Stakeholder Impact

• Shareholders benefit from the elimination of supermajority voting requirements, giving them more influence over company decisions.
• Non-employee directors are impacted by the new compensation policy, which outlines their cash and equity compensation.
• Employees are indirectly affected by the corporate governance changes, as these changes can influence the overall direction and management of the company.

Key Dates

Keywords

Director Compensation, Corporate Governance, Annual Meeting, Bylaws, Charter Amendment, Select Medical Holdings, Voting Rights, Board of Directors